Category: Chronic Pulmonary Disorders

Chronic Pulmonary Disorders

Evidence Supports Buprenorphine for Acute Pain in Patients with Opioid Use Disorder

Continuing buprenorphine during acute pain episodes for people with opioid use disorder (OUD) may lead to lower or similar pain severity compared to discontinuation.

Chronic Pulmonary Disorders

Immune Cell Networks Drive Pulmonary Fibrosis

Networks of misplaced immune cells drive idiopathic pulmonary fibrosis -- a discovery that may create a pathway to new treatments.

Chronic Pulmonary Disorders

Lower Cardiovascular Risks for Vapers with HIV Compared to Smokers with HIV

Vaping may have lower cardiovascular risks than cigarette smoking in patients with HIV, new JAHA research reports.

Asthma

Child Asthma Risk Increased by Early-Life Antibiotics

New research indicates that postnatal antibiotic exposure, not associated with additional respiratory infections, is associated with childhood asthma.

COPD

Mental Health Being Ignored in COPD Patients

Mental health disorders in people with COPD are underdiagnosed and undertreated, leading to worsened symptoms and decreased quality of life.

Cystic fibrosis

Inequities in Cystic Fibrosis Diagnosis

Researchers say a CF diagnosis within 10 days of birth compared to diagnosis within 6 weeks of birth can produce better height and weight outcomes.

Pulmonary Fibrosis

Surprisingly, Post-COVID-19 Pulmonary Fibrosis Tends to Resolve

Pulmonary fibrosis caused by severe COVID-19 shows a surprising tendency to resolve, offering new insights that may inform treatments for non-resolving forms of the disease.

Allergies

College Dining Halls Lack Safety Measures for Food Allergies

College dining halls lack ingredient labels and emergency epinephrine, leading to higher risk of food allergy exacerbations and anaphylaxis.

Other Chronic Diseases

Tezspire Significantly Reduced Nasal Congestion, Polyp Size in CRwNP Patients

Tezspire, an add-on maintenance treatment of adult and pediatric patients aged 12 years and older with severe asthma, showed significant benefits for patients with chronic rhinosinusitis with nasal polyps (CRSwNP) in a Phase 3 clinical trial.